Products & Services · Milestone payments

Alliance revenue - Koselugo — Milestone payments

Merck & Co. Alliance revenue - Koselugo — Milestone payments increased by 50.0% to $75.00M in Q3 2028 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $50.00M to $75.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ3 2028May 4, 2026

How to read this metric

An increase signals successful progress in product development or commercialization, while a decrease may indicate delays in meeting project milestones.

Detailed definition

This metric captures revenue recognized upon the achievement of specific, pre-defined events within a collaborative arra...

Peer comparison

Standard in pharmaceutical R&D collaborations where payments are tied to clinical or regulatory success.

Metric ID: mrk_segment_alliance_revenue_koselugo_milestone_payments

Historical Data

7 periods
 Q1 '25Q2 '25Q3 '25Q4 '25Q3 '26Q3 '27Q3 '28
Value$43.75M$43.75M$43.75M$43.75M$50.00M$50.00M$75.00M
QoQ Change+0.0%+0.0%+0.0%+14.3%+0.0%+50.0%
YoY Change+14.3%+0.0%+50.0%
Range$43.75M$75.00M
CAGR+43.2%
Avg YoY Growth+21.4%
Median YoY Growth+14.3%
Current Streak6+ quarters growth

Frequently Asked Questions

What is Merck & Co.'s alliance revenue - koselugo — milestone payments?
Merck & Co. (MRK) reported alliance revenue - koselugo — milestone payments of $75.00M in Q3 2028.
How has Merck & Co.'s alliance revenue - koselugo — milestone payments changed year-over-year?
Merck & Co.'s alliance revenue - koselugo — milestone payments increased by 50.0% year-over-year, from $50.00M to $75.00M.
What does alliance revenue - koselugo — milestone payments mean?
Revenue earned when specific development or regulatory goals are achieved in a partnership.